Arvind Remedies Ltd.
NSE: ARVINDREM | BSE: 531823
₹4.70
₹-0.24
(-4.86%)
As on 13-Jun-2016IST
Market cap
₹32 Cr
Revenue (TTM)
₹12 Cr
P/E Ratio
--
P/B Ratio
-0.2
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-320 Cr
-
ROE
-287.8 %
-
ROCE
-31.9 %
-
Industry P/E
40.16
-
EV/EBITDA
-8.6
-
Debt to Equity
2.3
-
Book Value
₹--
-
EPS
₹-20.2
-
Face value
10
-
Shares outstanding
68,126,000
10 Years Aggregate
CFO
₹-188.56 Cr
EBITDA
₹483.54 Cr
Net Profit
₹-148.08 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Arvind Remedies
| -17.1 | -6.4 | 10.1 | -64.0 | -45.7 | -28.9 | -10.4 |
|
BSE Sensex*
| -9.1 | 1.1 | 1.2 | -4.8 | 5.8 | 6.6 | 10.7 |
|
BSE Healthcare#
| 18.1 | 3.9 | 8.1 | 16.4 | 22.9 | 14.9 | 12.3 |
|
Company
|
2015
|
2014
|
|---|---|---|
|
Arvind Remedies
| -81.2 | -46.3 |
|
BSE Sensex
| -5.0 | 29.9 |
|
BSE Healthcare
| 15.1 | 47.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Arvind Remedies
|
4.7 | 32.0 | 12.3 | -137.4 | -980.7 | -- | -- | -0.2 |
| 3,329.2 | 27,295.8 | 1,461.8 | 387.4 | 34.5 | 25.2 | 70.7 | 15.8 | |
| 824.0 | 16,218.4 | 7,784.0 | 688.5 | 10.6 | 14 | 23.4 | 2.8 | |
| 454.0 | 17,364.2 | 2,141.5 | 58.5 | 5.8 | 3.3 | 163.5 | 4.5 | |
| 832.3 | 20,611.8 | 5,632.3 | 662.4 | 17.2 | 14.3 | 31.1 | 4.2 | |
| 1,517.5 | 17,416.5 | 1,543.3 | -48.6 | 3.6 | -0.6 | -- | 3.0 | |
| 215.0 | 28,624.0 | 9,205.3 | -371.8 | 1.7 | -3.8 | -- | 3.6 | |
| 1,841.0 | 30,553.9 | 1,935.8 | 288.2 | 20.6 | 29.8 | 106 | 22.8 | |
| 413.8 | 16,730.1 | 3,600.2 | 221.0 | 9.7 | 5.6 | 75.7 | 3.5 | |
| 1,962.0 | 31,877.7 | 3,564.0 | 414.0 | 15.3 | 8.4 | 77.9 | 6.3 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Arvind Remedies
Manufacture of allopathic pharmaceutical preparations
-
Incorporated
1988
-
Chairman
--
-
Managing Director
B Arvind Shah
-
Headquarters
Thiruvallur Dist, Tamil Nadu
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Arvind Remedies
What is the current share price of Arvind Remedies Ltd Today?
The share price of Arvind Remedies Ltd is ₹4.70 (BSE) and ₹12.60 (NSE) as of 13-Jun-2016 IST. Arvind Remedies Ltd has given a return of -45.67% in the last 3 years.
What is the current PB & PE ratio of Arvind Remedies Ltd?
Since, TTM earnings of Arvind Remedies Ltd is negative, P/E ratio is not available.
The P/B ratio of Arvind Remedies Ltd is -0.20 times as on 13-Jun-2016, a 105 discount to its peers’ median range of 4.16 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2014 |
5.03 |
1.07 |
2013 |
3.42 |
0.85 |
2012 |
52.69 |
0.80 |
2011 |
66.20 |
0.92 |
2010 |
46.44 |
0.86 |
What is the 52 Week High and Low of Arvind Remedies Ltd?
The 52-week high and low of Arvind Remedies Ltd are Rs -- and Rs -- as of 27-Aug-2026.
What is the market cap of Arvind Remedies Ltd?
Arvind Remedies Ltd has a market capitalisation of ₹ 32 Cr as on 13-Jun-2016. As per SEBI classification, it is a company.
Should I invest in Arvind Remedies Ltd?
Before investing in Arvind Remedies Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.